Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Abstract

BackgroundTo provide a clear picture of the current hepatitis B situation, the authors performed a systematic review to estimate the age- and region-specific prevalence of chronic hepatitis B (CHB) in Turkey.MethodsA total of 339 studies with original data on the prevalence of hepatitis B surface antigen (HBsAg) in Turkey and published between 1999 and 2009 were identified through a search of electronic databases, by reviewing citations, and by writing to authors. After a critical assessment, the authors included 129 studies, divided into categories: 'age-specific'; 'region-specific'; and 'specific population group'. To account for the differences among the studies, a generalized linear mixed model was used to estimate the overall prevalence across all age groups and regions. For specific population groups, the authors calculated the weighted mean prevalence.ResultsThe estimated overall population prevalence was 4.57, 95% confidence interval (CI): 3.58, 5.76, and the estimated total number of CHB cases was about 3.3 million. The outcomes of the age-specific groups varied from 2.84, (95% CI: 2.60, 3.10) for the 0-14-yearolds to 6.36 (95% CI: 5.83, 6.90) in the 25-34-year-old group.ConclusionThere are large age-group and regional differences in CHB prevalence in Turkey, where CHB remains a serious health problem.

The Seropositivity of Hepatitis B, Hepatitis C and HIV of the Healthcare Workers in Kırıkkale Mouth and Dental Health Center

“…Türkiye'de HBV aşısı 1980'den beri bulunması-na rağmen, 1998'den bu yana ulusal aşılama programına dâhil edilmiş, 1999'dan bu yana da sağlık çalışanlarına uygulanmaya başlanmıştır. Sağlık çalışanlarında 1999 sonrası HBV prevalansı incelendiğinde aşılama öncesine göre düşüş görülmüştür (7,8) .…”

Incidence of acute hepatitis B in patients with spinal cord injury

“…The prevalence of HBsAg positivity among patients who apply to hospitals ranges from 1.30 to 10.88%, depending on region. 15 The setting in which we conducted the study is a tertiary referral center and accepts patients from all over the country. A total of 11 patients (6.8%) had a history of known HBsAg positivity in our study.…”

“…18 Most of the adult population in many countries is not safeguarded against HBV. A recent study by Toy et al 15 has revealed that HBsAg seroprevelance in hospital setting varies between 1.30 and 10.88%, depending on the region in Turkey. The establishment of screening and vaccination protocols in high risk adult patients who are not included in vaccination programmes may prevent the spread of hepatitis B, health-care and financial losses.…”

Features of Hemodialysis in Cirrhotic Patients:Single Center Experience

“…Prevalence of the Hepatitis B in Turkey was estimated to be 4.57%; the same value is 6.72% in our region (Eastern Anatolia) (8). On the other hand, the prevalence of Hepatitis C is relatively low in the region, and it is estimated to be around 1% (ranging between 0.6-2.2%) (9).…”